TrovaGene
Why Robinhood?
You can watch TrovaGene and buy or sell other stocks, ETFs, and their options commission-free!About TROV
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.
TROV Key Statistics
Stock Snapshot
As of today, TrovaGene(TROV) shares are valued at $1.19. The company's market cap stands at 81.28M, with a P/E ratio of -2.43.
On 2026-05-18, TrovaGene(TROV) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 698.98K.
The stock's 52-week range extends from a low of $1.48 to a high of $4.56.
The stock's 52-week range extends from a low of $1.48 to a high of $4.56.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.